Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Part of paid clinical trials in Dallas, Texas.

Sponsor
Texas Woman's University
Study ID
NCT06313359
Status
Recruiting
Apply to this trial

Conditions

  • Peripheral Neuropathy Due to Chemotherapy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.

Key Dates

Start date
Mar 30, 2024
Status verified
Oct 2024
Primary completion
Dec 30, 2025
Completion
Jun 30, 2026

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Cancer treatment induced peripheral neuropathy
    Individuals with a history of non CNS cancer with cancer treatment induced peripheral neuropathy symptoms.
  • Arm: Control group
    Age and gender matched individuals without peripheral neuropathy symptoms.

Primary Outcome Measure

Fall risk [ Time Frame: 5 minutes ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Texas Woman's UniversityDallasTexas75235
Priya Karakkattil, PhD
[email protected]
214-689-7726

Find similar trials in Dallas, TX

By research site
Texas Woman's University· Dallas, TX

Related Studies